Whittaker Spinoff? Whittaker Corp. said it is...

Whittaker Spinoff? Whittaker Corp. said it is exploring the idea of spinning off its bioproducts division to stockholders. The Los Angeles company, which in recent years has divested all but its aerospace and biotech units, said its decision would depend in part on financing. The company also announced results for its third fiscal quarter ended July 31, which saw income from continuing operations rise to $4,025,000, or 47 cents a share, versus a loss of $3,213,000 a year earlier. Whittaker stock rose 75 cents to $10.50.